Chinese drug regulator fines Changsheng Bio-Tech unit over vaccine scandal

Chinese drug regulator fines Changsheng Bio-Tech unit over vaccine scandal


China's drug regulator imposed penalties on a unit of Changsheng Bio-Technology worth 9.1 billion yuan over a vaccine scandal, Xinhua news agency said on Tuesday. FILE PHOTO: A sign of vaccine maker Changsheng Bio-technology Co Ltd is pictured at its building in Changchun, Jilin, China July 23, 2018.



from Biotech News